FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035888287> ?p ?o ?g. }

• W3035888287 abstract "Research Objectives: Many Medicare Part D prescription drug plans include a coverage gap when beneficiaries’ spending exceeds an annual threshold. Early evidence suggests that the gap is associated with reductions in drug adherence. An increasing number of plans offer supplemental coverage during the gap, including generic-only drug coverage; however, little is known about the impact of generic-only coverage during the gap or about how effects may differ for beneficiaries using brand versus generic drug regimens. Study Design: We conducted a historical cohort study to examine chronic drug therapy adherence for three therapeutic classes (cholesterol, diabetes, blood thinners) in 2007. We measured drug use using the proportion of days covered (PDC) by any drug in the class, and defined adherence as PDC≥80%. To examine annual differences in adherence we used random-effects models adjusted for age, gender, and the Part D risk score (RxHCC). We also examined changes in adherence in the five months before and after beneficiaries entered the gap using within-person fixed effects models, and defined patients’ drug use as brand or generic based on use in the month prior to entering the gap. Population Studied: The study population included Part D beneficiaries enrolled in stand-alone Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug (MAPD) plans offered by a large national plan sponsor. Beneficiaries receiving employer sponsored benefits or low income subsidies were excluded. Principal Findings: Among PDP beneficiaries, generic-only gap coverage was associated with higher PDC and adherence in each drug class compared with no gap coverage (e.g., OR=1.88, 95% CI: 1.85-1.92 for adherence to cholesterol drugs); among MAPD beneficiaries findings varied by drug class. Entering the gap was associated with significant reductions in drug supply for cholesterol and oral diabetes drugs for PDP and MAPD beneficiaries with a gap and generic-only gap coverage; however the magnitude of the reductions were larger for beneficiaries using brand versus generic drugs (p<0.05). Beneficiaries using generic drugs prior to entering the gap who were enrolled in plans providing generic-only gap coverage had the smallest reductions in use. Differences across groups were not significant for changes in use of blood thinners. Conclusions: Patients reduced use of chronic drugs after entering the coverage gap. Brand drug users all experienced substantial reductions in adherence to cholesterol and oral diabetes drugs after reaching the gap. Generic-only gap coverage conferred modest benefits for generic drug users, compared to plans with the coverage gap, but was still associated with modest declines in drug use after reaching the gap. Implications: Standard Part D drug plans with gaps in coverage are associated with poor adherence, particularly for beneficiaries taking brand drugs. Partial coverage plans that provide generic drug coverage during the gap offer only some coverage improvement. Additional efforts are needed to identify approaches for covering all necessary chronic drugs." @default.
• W3035888287 created "2020-06-25" @default.
• W3035888287 creator A5029899829 @default.
• W3035888287 creator A5040474455 @default.
• W3035888287 creator A5051014281 @default.
• W3035888287 creator A5055066308 @default.
• W3035888287 creator A5091214606 @default.
• W3035888287 date "2010-06-01" @default.
• W3035888287 modified "2023-09-26" @default.
• W3035888287 title "The Medicare Part D Coverage Gap and Chronic Drug Use: Impact of Brand Versus Generic Use" @default.
• W3035888287 hasPublicationYear "2010" @default.
• W3035888287 type Work @default.
• W3035888287 sameAs 3035888287 @default.
• W3035888287 citedByCount "0" @default.
• W3035888287 crossrefType "posted-content" @default.
• W3035888287 hasAuthorship W3035888287A5029899829 @default.
• W3035888287 hasAuthorship W3035888287A5040474455 @default.
• W3035888287 hasAuthorship W3035888287A5051014281 @default.
• W3035888287 hasAuthorship W3035888287A5055066308 @default.
• W3035888287 hasAuthorship W3035888287A5091214606 @default.
• W3035888287 hasConcept C126322002 @default.
• W3035888287 hasConcept C144024400 @default.
• W3035888287 hasConcept C149923435 @default.
• W3035888287 hasConcept C160735492 @default.
• W3035888287 hasConcept C162324750 @default.
• W3035888287 hasConcept C2426938 @default.
• W3035888287 hasConcept C2776291444 @default.
• W3035888287 hasConcept C2776396487 @default.
• W3035888287 hasConcept C2778176773 @default.
• W3035888287 hasConcept C2778829437 @default.
• W3035888287 hasConcept C2778858636 @default.
• W3035888287 hasConcept C2780035454 @default.
• W3035888287 hasConcept C2908647359 @default.
• W3035888287 hasConcept C50522688 @default.
• W3035888287 hasConcept C512399662 @default.
• W3035888287 hasConcept C71924100 @default.
• W3035888287 hasConcept C72563966 @default.
• W3035888287 hasConcept C98274493 @default.
• W3035888287 hasConcept C99454951 @default.
• W3035888287 hasConceptScore W3035888287C126322002 @default.
• W3035888287 hasConceptScore W3035888287C144024400 @default.
• W3035888287 hasConceptScore W3035888287C149923435 @default.
• W3035888287 hasConceptScore W3035888287C160735492 @default.
• W3035888287 hasConceptScore W3035888287C162324750 @default.
• W3035888287 hasConceptScore W3035888287C2426938 @default.
• W3035888287 hasConceptScore W3035888287C2776291444 @default.
• W3035888287 hasConceptScore W3035888287C2776396487 @default.
• W3035888287 hasConceptScore W3035888287C2778176773 @default.
• W3035888287 hasConceptScore W3035888287C2778829437 @default.
• W3035888287 hasConceptScore W3035888287C2778858636 @default.
• W3035888287 hasConceptScore W3035888287C2780035454 @default.
• W3035888287 hasConceptScore W3035888287C2908647359 @default.
• W3035888287 hasConceptScore W3035888287C50522688 @default.
• W3035888287 hasConceptScore W3035888287C512399662 @default.
• W3035888287 hasConceptScore W3035888287C71924100 @default.
• W3035888287 hasConceptScore W3035888287C72563966 @default.
• W3035888287 hasConceptScore W3035888287C98274493 @default.
• W3035888287 hasConceptScore W3035888287C99454951 @default.
• W3035888287 hasLocation W30358882871 @default.
• W3035888287 hasOpenAccess W3035888287 @default.
• W3035888287 hasPrimaryLocation W30358882871 @default.
• W3035888287 hasRelatedWork W1973909165 @default.
• W3035888287 hasRelatedWork W1983335365 @default.
• W3035888287 hasRelatedWork W2083619573 @default.
• W3035888287 hasRelatedWork W2100089659 @default.
• W3035888287 hasRelatedWork W2107265020 @default.
• W3035888287 hasRelatedWork W2165798184 @default.
• W3035888287 hasRelatedWork W2169376902 @default.
• W3035888287 hasRelatedWork W2195735881 @default.
• W3035888287 hasRelatedWork W2325343059 @default.
• W3035888287 hasRelatedWork W2329028486 @default.
• W3035888287 hasRelatedWork W2338932242 @default.
• W3035888287 hasRelatedWork W2347041144 @default.
• W3035888287 hasRelatedWork W2510732576 @default.
• W3035888287 hasRelatedWork W3092589561 @default.
• W3035888287 hasRelatedWork W3141647278 @default.
• W3035888287 hasRelatedWork W3157594958 @default.
• W3035888287 hasRelatedWork W3195970630 @default.
• W3035888287 hasRelatedWork W2184472576 @default.
• W3035888287 hasRelatedWork W2185037670 @default.
• W3035888287 hasRelatedWork W2188088385 @default.
• W3035888287 isParatext "false" @default.
• W3035888287 isRetracted "false" @default.
• W3035888287 magId "3035888287" @default.
• W3035888287 workType "article" @default.